Use of aborted fetal tissue in vaccines and medical research obscures the value of all human life

Abstract

This opinion addresses the licitness, quasi-benefits, and consequences of using aborted fetal tissue in vaccines and in medical research. The Catholic Church permits temporary use of vaccines generated using aborted fetal tissue to protect children from preventable diseases until alternative vaccines that do not use aborted fetal tissue are available. In medical research, cell lines that were generated from elective abortions should be avoided and alternative cell lines of licit origin utilized. The association between in utero Zika virus infections and microcephaly has increased the demand for fetal tissue to establish causality and to understand disease progression. These studies require extensive oversight as they could directly encourage elective abortions. The consequence of the use of fetal tissue from elective abortions is desensitization of beneficiaries to the original illicit act of abortion thereby obscuring the value of all human life and potentially leading to scandal.

Summary: The use of fetal tissue from elective abortions is commonplace in the pharmaceutical industry and in medical research. This opinion addresses the licitness, quasi-benefits, and consequences of using fetal tissue from elective abortions in vaccines and in medical research. All people of good conscience have the responsibility to voice opposition to the use of fetal tissue from elective abortions in order to promote development of alternatives, affirm the value of all human life and limit scandal.

Keywords:

• Ethics
• Abortion
• Vaccine
• Research
• Fetal tissue

Notes

1. A search of NCBI databases for “HEK293,” ttp://www.ncbi.nlm.nih.gov/gquery/?term=HEK293.

Additional information

Notes on contributors

Kyle Christopher McKenna

Kyle Christopher McKenna, Ph.D., is an associate professor of Biology at Franciscan University of Steubenville, Steubenville, Ohio, USA.